Anborela
ANBORELA EUROPEAN INDEPENDENT AI
PRE-DEPLOYMENT ETHICS REVIEW GDPR COMPLIANT EU AI ACT ALIGNED 100% EUROPEAN INFRASTRUCTURE

Research · Statistical evidence base

Women & Addictions
in the European Union

A comprehensive evidence review across prevalence, the gender gap, access barriers, existing responses and institutional frameworks — covering all 27 EU member states and the United Kingdom.

27+UK Countries covered
7 Primary source categories
2026 Latest data: EUDA FAQ
8 Documented structural barriers
Block 01 · Prevalence

The scale of the problem in Europe

Europe holds the world's highest alcohol consumption per capita. Eight of the ten countries with the greatest per-capita intake belong to the WHO European Region.

36M Women in the EU who have used an illicit substance at least once in their lifetime EUDA Statistical Bulletin 2025
9.2L Litres of pure alcohol consumed per capita per year — the highest region globally WHO/EU Alcohol Fact Sheet 2024
17.9% Adult women in the EU with heavy episodic drinking (HED) episodes EUDA 2025
114M Adults in the EU reporting heavy episodic alcohol consumption The Lancet Regional Health – Europe 2024
Key findings

Substance use patterns

  • Cannabis remains the most widely used illicit drug. Among 15–16 year-olds (ESPAD 2024, 37 countries), 14% report lifetime use.
  • Gender convergence — differences narrow significantly in younger generations, signalling an emerging prevalence shift.
  • Telescope effect — women progress from first use to dependence significantly faster than men, across most substance categories.
  • Alcohol causal link — alcohol is responsible for almost 1 in 11 deaths in the European region and is causally linked to more than 200 diseases.

Sources: EUDA Statistical Bulletin 2025 · ESPAD 2024 · WHO/EU Alcohol Fact Sheet Oct. 2024 · The Lancet Regional Health – Europe 2024

Context

Why this matters for AI-assisted support

  • The sheer scale of unmet need creates a structural gap that digital, low-threshold tools are uniquely positioned to address.
  • Women's faster progression toward dependence argues for earlier, more accessible intervention — before clinical thresholds are reached.
  • Anonymous conversational AI offers a first-contact channel that carries none of the stigma barriers attached to formal services.
  • The ANBORELA system is designed precisely for this pre-clinical, high-need population.

ANBORELA analysis based on EUDA 2025–2026 evidence base

Block 02 · Gender gap

The invisible problem: who uses vs who receives help

Women represent 25% of serious drug cases across Europe, yet account for only 20% of those entering specialised treatment. The gap is not in consumption — it is in access.

Men vs Women · across four indicators

Who uses — and who gets treated

Men Women
Illicit drug use (lifetime)
Men
59%
Women
41%
Serious drug problems
Men
75%
Women
25%
In specialised treatment
Men
80%
Women
20%
Heavy episodic drinking (HED)
Men
43%
Women
18%

Sources: EUDA Gender and drugs FAQ (March 2026) · EUDA Women and drugs mini-guide · EUDA International Women's Day 2019

~2,000 Overdose deaths among European women annually
100K Women accessing specialised treatment each year in Europe
20% Women in treatment — despite being 50% of the population
Telescope effect Women progress significantly faster from first use to full dependence — yet are last to reach treatment services.
Block 03 · Behavioural addictions

A different map for women

Women present distinct profiles across non-substance addictions — often with faster progression, later onset, and higher psychiatric comorbidity than men in the same category.

Addiction type Men (prevalence) Women (prevalence) Specific pattern in women Source
Gambling disorder (Europe) 4.5% 2.9% Faster progression; later onset; higher psychiatric comorbidity. Prefer lottery-style over skill games. Lancet 2024
Gambling disorder (global) 54.7M cases 25.3M cases Prefer games of chance (lottery) over games of skill. Heavily under-represented in help-seeking. Lancet 2024
Gaming disorder (adolescents) 6.8% 1.3% Sexual minority women: OR ×2.3 elevated risk. Low detection in services due to gender assumptions. ESPAD 2024
Internet / shopping addiction Lower risk Higher risk Used as coping mechanism; linked to gender roles and social isolation. Under-pathologised clinically. Pompidou 2024
4% Only 4% of people with problematic gambling actively seek professional help. Women are even less likely to self-identify as having a gambling problem because they maintain social bonds through the behaviour.
2.7–6.5% Range of at-risk online gambling prevalence among adults in the EU. Digitisation accelerates problem development, particularly in women. No EU-wide effectiveness evaluation of digital interventions currently exists.

Sources: The Lancet 2024 · ESPAD 2024 · Council of Europe Pompidou Group 2024 · PMC/Frontiers Behavioural Addiction 2022–2023

Block 04 · Barriers to access

Why women do not seek help: 8 documented structural barriers

These are not individual failures. They are systemic, structural, and reinforcing. Each one alone is enough to prevent help-seeking; in combination, they are insurmountable without targeted intervention.

01 Social
Double stigma
Being a woman who uses substances violates gender roles — as carer, mother, and social anchor. Stigma intensifies dramatically during pregnancy and motherhood.
02 Legal / Familial
Fear of losing custody
The most frequently cited barrier in European literature. Seeking help risks triggering child protection proceedings, making silence the rational — and devastating — choice.
03 Economic
Unaffordable care
41% of women cannot cover an unexpected dental cost. 39% find mental health services unaffordable — compared to 33% of men. The gender pay gap extends into healthcare access.
04 Systemic
Services designed for men
The majority of addiction services were built around male schedules, language, and culture. Women entering them encounter an environment that was never designed to serve them.
05 Clinical
Trauma as origin
High prevalence of gender-based violence and childhood sexual abuse. Substance use frequently begins as a coping mechanism for unaddressed trauma — not as recreational choice.
06 Logistical
Caregiving conflict
Incompatible service hours, lack of integrated childcare, transport barriers. Services that require a woman to choose between treatment and her children are not accessible services.
07 Clinical
Missed diagnosis
Women seek help through physical health, mental health, or gynaecology routes — where the addiction is rarely detected. The problem remains invisible at the very point where it could be addressed.
08 Intersectional
Compounded discrimination
LGBTIQ+ women, migrants and ethnic minorities face compounded barriers: language, legal status, homophobia in services, and heightened fear of institutional contact.

Sources: EUDA FAQ Gender and Drugs 2026 · European Parliament Gender Inequalities in Medical Research 2025 · EUDA mini-guide Women and Drugs

Block 05 · Existing responses

What exists today: documented programmes across the EU

Several evidence-based models have demonstrated effectiveness for women. Coverage, however, remains deeply unequal across member states — and digital, low-threshold options are systematically underdeveloped.

Most effective

Women-only services

Delivered by women, for women — with integrated attention to trauma, gender-based violence, maternity and mental health. Identified by EUDA as the most effective response for women with a history of intimate partner violence.

  • Coverage remains very uneven between countries
  • Demand consistently outstrips availability
  • Models from Ireland and the Netherlands cited as leading practice
Perinatal

Integrated perinatal programmes

Simultaneous treatment of addiction and pregnancy or new motherhood — including prenatal care, parenting education, and accommodation that allows children to remain with their mothers during treatment.

  • Portugal (ICAD), Ireland (HRB) and the Netherlands cited as leaders
  • Directly addresses the custody barrier
  • High retention rates compared to standard services
European standard

Trauma-informed care

The European standard recommended by EUDA and the Pompidou Group. Requires safe, non-judgemental environments with gender perspective and systematic coordination with gender-based violence services.

  • Recommended across all 27 EU member states
  • Implementation highly variable in practice
  • Requires sustained professional training investment
Digital · Low-threshold

Anonymous & digital access

Anonymous peer groups (AA, NA), helplines, and online/hybrid care. Critical for women who do not present in person. Prioritised by the Pompidou Group and EUDA for 'invisible' populations — yet systematically under-evaluated.

  • No EU-wide effectiveness evaluation currently exists
  • Demand signals far exceed current supply
  • ANBORELA is designed to operate within this evidence gap
Primary care

Detection in adjacent systems

Women reach services through mental health, gynaecology or emergency routes — where addiction is rarely identified. Training primary care staff in gender-sensitive detection is a stated EU Action Plan priority.

  • Low implementation rate across primary care networks
  • Structural disconnect between addiction and mental health services
  • AI-assisted screening tools represent an emerging opportunity
Block 06 · Research & publications

What we know — and what is still missing

The ANBORELA evidence base draws exclusively on peer-reviewed publications, EU agency primary data, and international health organisation reports. Critical research gaps define the frontier where ANBORELA aims to contribute.

Verified primary sources

Evidence base

  • EUDA — Gender and Drugs FAQ (March 2026)
  • EUDA — European Drug Report 2025
  • EUDA — ESPAD 2024 (adolescents, 37 countries)
  • WHO/Europe — Alcohol Fact Sheet (October 2024)
  • The Lancet — Gambling disorder global (2024)
  • Brain Sciences — Gender perspective dual diagnosis (2021)
  • European Psychiatry — AUD in women (August 2025)
  • Council of Europe — Online gambling risks (2024)
  • European Parliament — Gender inequalities in medical research (2025)
  • Pompidou Group — Behavioural addictions & women (2024)
Documented research gaps

Where evidence is missing

Gender-based violence & addiction — systematic EU-wide data remains insufficient (EUDA 2023)
Trans & non-binary identities — data almost entirely absent from current reporting systems
Behavioural addictions in women — scarcity of European longitudinal studies
Dual diagnosis in women — under-represented in clinical research despite high real-world prevalence
Digital low-threshold interventions — no EU-wide effectiveness evaluation of existing digital tools
Migrant women with addictions — data almost entirely absent from national reporting systems
Block 07 · Institutional framework

Who regulates, coordinates and funds in the EU

Understanding the regulatory landscape is critical for any research partnership. ANBORELA has been designed from inception to operate within — and contribute to — this institutional architecture.

EU level

European institutions

  • EUDA — European technical regulator for drugs policy
  • Reitox Network — 27 national focal points
  • European Commission + Council of the EU (policy)
  • Pompidou Group — Council of Europe
  • WHO Europe · Eurocare · EUREC (ethics)
National level

Member state bodies

  • Ministry or national agency (Reitox focal point)
  • National or university/hospital ethics committee
  • Country-specific NGOs and low-threshold networks
  • Anonymous peer groups (AA, NA) — active European network
ANBORELA approach

Designed for this ecosystem

  • Anonymous and digital access — no barriers to entry
  • Trauma-informed, non-punitive design by default
  • No threat to maternity — custody-neutral architecture
  • Coordination-ready with mental health & GBV services
  • Low-threshold: no appointment, no name, no cost
  • Pre-deployment ethics review before any public access
Key conclusions

The evidence in four figures

20% Women are only 20% of those in specialised treatment, despite being 50% of the population. The access gap — not consumption — is the central problem.
8 Eight documented structural barriers prevent women from seeking help. Double stigma and fear of losing custody are the most cited across European literature.
4% Only 4% of people with gambling disorder actively seek help. In behavioural addictions, anonymous digital access is critical — and critically underdeveloped at EU scale.
0 There is no single European ethics committee for addictions research. Approval operates at national level: ministerial, university or hospital. ANBORELA submits voluntarily to each relevant body.

Is your institution ready to co-design the evidence?

We invite European universities, public health institutes and research bodies to join the ANBORELA scientific steering group. Ethics-first, GDPR-compliant, Big-Tech-independent. Open to EU and UK partners.

Start the conversation → European network
Sources: EUDA 2025–2026 · WHO Europe 2024 · The Lancet 2024 · European Parliament 2025 · Pompidou Group · ESPAD 2024 · Brain Sciences 2021 · European Psychiatry 2025